How to Treat Opiate Withdrawal in Neonates

Status Completed

Clinical Trial Summary

Three different drugs are used in a randomised, double blind, clinical multi-centre trial with three arms. Major objective is to investigate the duration of drug treatment based on the Finnegan score. Secondary objectives are to document weight gain, the need for adding a second drug when the first drug is not effective enough and possible side effects such as convulsions.

Clinical Trial Description

Background: Neonatal narcotic abstinence syndrome is an important medical, social and financial problem. Several drugs are used to treat the withdrawal symptoms in neonates that have been exposed to opiates in utero, but there is no consensus which one is best.

Goal: Three different drugs are used in a randomised, double blind, clinical multi-centre trial with three arms. Major objective is to investigate the duration of drug treatment based on the Finnegan score. Secondary objectives are to document weight gain, the need for adding a second drug when the first drug is not effective enough and possible side effects such as convulsions.

Methods: Neonates born after 34 completed weeks of gestation with meconium proven antenatal opiate exposure and parental informed consent are included. Infants with severe malformation are excluded. Each infant is assessed every eight hour by a modified Finnegan score. When 9 points are exceeded drug treatment is started and dose increased stepwise according to the score. The masqued solution applied orally contains morphine, phenobarbital or chlorpromazine. When the maximum dose does not reduce the score, a second randomisation and one of the two remaining drugs is added, again in a blinded way.

A total of 120 infants, 40 in each group will be included in the study. ;

Study Design

Related Conditions & MeSH terms

Neonatal Abstinence Syndrome

Clinical Trial Details

NCT number	NCT02810782
Study type	Interventional
Source	University of Zurich
Contact
Status	Completed
Phase	Phase 3
Start date	June 2001
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01965704` - Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women	Phase 2
Completed	`NCT03890562` - Assessing the Effects of Auricular Acupressure on Newborns With NAS	N/A
Completed	`NCT01958476` - Improving Outcomes in Neonatal Abstinence Syndrome	Phase 3
Active, not recruiting	`NCT01734551` - NAS Treatment - Opiate Versus Non-Opiate	Phase 4
Completed	`NCT00496951` - Vagal Tone and Neonatal Abstinence Syndrome	N/A
Completed	`NCT02851303` - Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome	Phase 4
Recruiting	`NCT05226624` - The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program	N/A
Completed	`NCT03670160` - Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome	Phase 2
Not yet recruiting	`NCT04611659` - Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine	N/A
Completed	`NCT01452789` - Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome	Phase 3
Completed	`NCT04588519` - tAN to Mitigate Withdrawal Behaviors in Neonates	N/A
Completed	`NCT02797990` - Conflict Between Maternal Autonomy and Child Health in Substance-use	N/A
Completed	`NCT02801331` - Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence Syndrome	N/A
Terminated	`NCT03246243` - Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk
Completed	`NCT03567603` - Sound Processing Changes in Babies With Opioid Exposure
Recruiting	`NCT06303986` - Study to Collect Data for Neonatal Abstinence Syndrome (NAS) and Evaluate the Automated Data Collection Process
Active, not recruiting	`NCT03725332` - The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky	N/A
Recruiting	`NCT04983563` - Actigraphy and Neonatal Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units	N/A
Completed	`NCT04298853` - Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome	Phase 4
Completed	`NCT02182973` - Donor Human Milk in Neonatal Abstinence Syndrome